Geneva, July 7 -- International Clinical Trials Registry received information related to the study (NCT07656792) titled 'A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood' on June 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Boehringer Ingelheim
Condition:
Healthy
Intervention:
Drug: BI 3031185
Drug: Placebo matching BI 3031185
Drug: Midazolam
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: July 15, 2...